Actavis is a generic pharmaceutical companies, specializing in the development, manufacture and sale of generic pharmaceuticals. The company has operations in more than 40 countries, with over 10,000 employees. At present, Actavis has a portfolio which includes more than 1,000 medicines present on the market and registered in more than 70 countries.
Actavis Group was acquired by Allergan on April 25, 2012.
Join Mergr to view all 120 acquisitions of life science companies in 2012, including 19 acquisitions by private equity firms, and 101 by strategics.
Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.
Join Mergr to view this profile - and discover more life science acquisitions of companies like Actavis Group.
No obligation. Cancel anytime.